Cannabis

Acquisitions could boost Curaleaf’s production and retail footprint significantly. With the EBITDA expected to rise over the next two years, there’s significant upside.

Most US states are looking forward to cannabis legalization in 2020. Recently, Governor Andrew Cuomo promised to legalize cannabis in New York in 2020.

On January 10, HEXO was trading at 1.74 Canadian dollars, a fall of 63.1% since the beginning of 2019 and a discount of 84.6% to its 52-week high.

On January 12, GW Pharmaceuticals announced its preliminary unaudited product sales report for the fourth quarter and 2019.

Cronos Group (CRON) stock rose 33% with a heavy volume in after-hours trading on Wednesday. Marijuana stocks are on a rollercoaster ride.

Cannabis demand is rising, but there seems to be a gap between cannabis demand and supply in Canada. Let’s take a closer look at the imbalance.

Recently, Tilray said it was expanding its footprint to Israel. The company exported its first commercial medical cannabis shipment to Israel last week.

TerrAscend’s recent private placement was oversubscribed due to strong investor interest. It increased the offering to about $30 million from $20 million.

Aphria impressed analysts and cannabis investors in 2019. While the cannabis sector’s struggles pulled down Aphria stock, the company did well overall.

Today, Aurora Cannabis (ACB) was trading 11.2% higher at 12:06 PM ET. The company had lost 63.3% of its stock value YTD as of Monday.

Aurora Cannabis (ACB) has had a tough year. The stock is down 63.1% in 2019. Let’s see how analysts have lowered their expectations for it in recent months.

Donald Trump has never openly supported marijuana legalization, and this month, Trump has shared some conflicting views on medical marijuana legalization.

Canopy Growth has focused on its acquisition strategy since Canada legalized cannabis in 2018, expanding its medical cannabis market in Europe and globally.

Since Florida legalized medical marijuana, business is booming. In September, the state had 22 licensed vertically integrated medical cannabis operators.

Aurora Cannabis (ACB) (ACB.TO) is a Canadian cannabis giant, but the company’s plans to enter the US market keep getting delayed.

On Wednesday, OrganiGram (OGI) (OGI.TO) announced an equity program. Broadly, we think that the program is bad news for investors.

Aurora Cannabis’s Q1 cash cost of production fell to 0.85 Canadian dollars. Aurora credited its Sky facility’s cost-efficient cannabis cultivation.

Marijuana legalization in the US remains in limbo. Most Democrats have endorsed marijuana legalization. However, Republicans have yet to embrace it fully.

Recreational marijuana is now legal in Michigan. It took the step in 2018, but the licensing process and regulations took awhile.

We’ve previously discussed the varying degrees of marijuana legalization in a variety of US states. Now, let’s talk about the laws in Hawaii.

Cronos Group’s position in the CBD cosmetics market could be beneficial. The company is an established player in the market with the potential to grow 31%.

In today’s Get Real, we took a closer look at Uber’s trouble and an unexpected boost for Canopy Growth while markets react to more unrest.

Aurora Cannabis reported its third-quarter results after the market closed on November 14. Despite some positives, it fell 18% on November 15.

Cowen & Co. increased its estimates for the US cannabis market, expecting $85 billion in sales by 2030. Its previous sales forecast was $80 billion.

In today’s Get Real, we saw updates on Disney+, another round of trouble for Facebook, a potential threat to Tesla, and much more.

It’s been quite the whipsaw week for cannabis stocks, to put it mildly. First, there was the “Drake spike.” Then came the earnings disappointments.

Leading cannabis producer Canopy Growth reported disappointing fiscal 2020 second-quarter earnings results on November 14.

In today’s Get Real, we saw the rationale of recession fears, the latest about Tesla’s European Gigafactory, Nike’s departure from Amazon, and more.

In today’s Get Real, we saw President Trump’s concerns about vaping, the reception of the Disney+ launch, tension in the EV world, and more.

Twitter is dealing with a scandal and Airbus seems to be making the most of the Boeing crisis. Plus, Canopy Growth has a new partner.

Legal cannabis in Mexico is going through several twists and turns. The country first allowed medical marijuana in June 2017.

Charlotte’s Web Holdings (CWEB) (CWBHF) will report third-quarter earnings before the market opens on November 13. Let’s look at analysts’ expectations.

In today’s Get Real, we saw Tesla’s plans for China, AMD’s expectations for 2020, the state of crude oil prices, and more.

Charlotte’s Web Holdings has fallen 15.44% on the Toronto Stock Exchange. Its stock has dropped 43.58% on the TSE since its Q2 earnings on August 14.

Canopy Growth (CGC) is set to release its fiscal 2020 second-quarter earnings results on November 14. Let’s take a look at the word on Wall Street.

AT&T stock is prospering, while Netflix’s problems could be rising. We also have the latest earnings including U.S. Steel and Chevron today.

Curaleaf Holdings, Inc. (CURLF) (CURA) recently closed a deal with Acres Cannabis. Curaleaf bought Acres’ cultivation and production facilities in Amargosa Valley, Nevada. This 269,000-square-foot facility is for processing. With this deal, the company can expand its cultivation and processing operations in Nevada. Details of the deal On March 18, 2019, Curaleaf signed a deal […]

Cannabis is an evolving sector. Recently, Warren Buffett entered the space following Kraft Heinz’s (KHC) newest investment in Flowhub.

After closing in the red yesterday, the US equity market was trading marginally higher today. The cannabis sector is also up—and here’s why.

In today’s Get Real, we saw that several third-quarter results are out and all over the board. We also have recommendations for stocks to watch going forward.